CRANBURY, N.J., June 10 /PRNewswire-FirstCall/ -- Innophos Holdings, Inc. (Nasdaq: "IPHS") announced today that a sale of 4,600,000 shares of its common stock through an underwritten, secondary public offering had been completed. The distribution included 4,000,000 shares offered primarily by affiliates of Bain Capital Investors, LLC, plus an over-allotment option that was exercised by the underwriters for an additional 600,000 shares from the selling stockholders.
The secondary offering involved stock previously issued by Innophos and did not affect the 20,885,791 currently outstanding shares. None of the shares were sold by Innophos, and it will not receive any proceeds from the transaction. The shares sold in the offering represent approximately 22% of Innophos' outstanding common stock.
Lead managers for the offering were JP Morgan and Oppenheimer & Co. with Credit Suisse, UBS Investment Bank and BB&T Capital Markets acting as co-managers. A written prospectus relating to the offering may be obtained from:
J.P. Morgan Securities Inc. at 4 Chase Metrotech Center, CS Level,
Brooklyn, NY 11245, Attention: Prospectus Department, e-mail:
This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any State or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such State or jurisdiction.
Safe Harbor for Forward-Looking and Cautionary Statements
This press release and the documents referred to herein contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. As such, final results could differ from estimates or expectations due to risks and uncertainties, including but not limited to: incomplete or preliminary information; changes in government regulations and policies; continued acceptance of Innophos' products and services in the marketplace; competitive factors; technological changes; Innophos' dependence upon third-party suppliers; and other risks. For any of these factors, Innophos claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, as amended.
About Innophos Holdings, Inc.
Innophos Holdings, Inc. (http://www.innophos.com/), the holding company for a leading North American manufacturer of specialty phosphates, serves a diverse range of customers across multiple applications, geographies and channels. Innophos offers a broad suite of products used in a wide variety of food and beverage, consumer products, pharmaceutical and industrial applications. Innophos' market-leading positions derive from its experience and dedication to customer service and innovation. Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations in Nashville, TN; Chicago Heights, IL; Chicago (Waterway), IL; Geismar, LA; Port Maitland, ON (Canada); and Coatzacoalcos, Veracruz and Mission Hills, Guanajuato (Mexico).
IPHS-G
